The relative cost effectiveness of insulin glargine versus NPH insulin using UK real life data in type I diabetes mellitus

被引：0

作者：

McEwan, P.

Mehin, N.

Tetlow, A. P.

Sharplin, P.

机构：

[1] Univ Cardiff Wales, Cardiff, S Glam, Wales

[2] Sanofi Aventis, Paris, France

[3] CRC, Cardiff, S Glam, Wales

来源：

VALUE IN HEALTH | 2007年 / 10卷 / 03期

关键词：

D O I：

10.1016/S1098-3015(10)68736-0

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：A65 / A65

页数：1

共 50 条

[1] The relative cost effectiveness of insulin glargine versus nph insulin using UK real life data in patients with type 2 diabetes mellitus
McEwan, P.
Mehin, N.
AP, Tetlow
Sharplin, P.
[J]. VALUE IN HEALTH, 2007, 10 (03) : A64 - A65
[2] The relative cost effectiveness of insulin glargine versus NPH insulin using UK real life data in type I diabetes mellitus and the combined effect of HBAIC and hypoglycaemia reduction
McEwan, P.
Mehin, N.
Tetlow, A. P.
Sharplin, P.
[J]. VALUE IN HEALTH, 2007, 10 (06) : A262 - A263
[3] The relative cost effectiveness of insulin glargine versus detemir insulin using UK real life data in patients with type 2 diabetes mellitus
Tetlow, A. P.
McEwan, P.
Gordon, J.
[J]. DIABETOLOGIA, 2008, 51 : S406 - S406
[4] The relative cost effectiveness of insulin glargine versus NPH insulin in the UK in people with type 1 diabetes
McEwan, P.
Poole, C. D.
Holmes, P.
Tetlow, A. P.
Currie, C. J.
[J]. VALUE IN HEALTH, 2006, 9 (06) : A225 - A226
[5] The relative cost effectiveness of switching to insulin glargine versus NPH insulin in insulin naive and non insulin naive type 2 diabetes patients using UK real life data
McEwan, P.
Mehin, N.
Tetlow, A. P.
Sharplin, P.
[J]. VALUE IN HEALTH, 2007, 10 (06) : A223 - A223
[6] Evaluation of the cost-effectiveness of insulin glargine versus NPH insulin for the treatment of type 1 diabetes in the UK
McEwan, Phil
Poole, Chris D.
Tetlow, Tony
Holmes, Paul
Currie, Craig J.
[J]. CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 : S7 - S19
[7] Evaluation of the cost-effectiveness of insulin glargine versus NPH insulin for the treatment of type 2 diabetes in the UK
McEwan, Phil
Poole, Chris D.
Tetlow, Tony
Holmes, Paul
Currie, Craig J.
[J]. CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 : S21 - S31
[8] Effect of insulin glargine and nph insulin on quality of life in patients with type 2 diabetes mellitus
Gupta, K. S.
Gupta, U.
[J]. VALUE IN HEALTH, 2007, 10 (03) : A70 - A70
[9] Insulin glargine versus NPH insulin in patients with type 1 diabetes
Ratner, R
[J]. DRUGS OF TODAY, 2003, 39 (11) : 867 - 876
[10] Cost-effectiveness of Insulin Degludec Versus Insulin Glargine in Adults with Type 1 and Type 2 Diabetes Mellitus
Evans, Marc
Chubb, Barrie
Gundgaard, Jens
[J]. DIABETES THERAPY, 2017, 8 (02) : 275 - 291

← 1 2 3 4 5 →